RE:RE:Last day for tax-loss selling is today!Awful questions, emmitfitzhume. Perfectly appropriate, but awful.
My guess is that Bioasis cannot allow any deals to happen - a standstill - to prevent a re-evaluation of the deal.
The Bioasis/Janssen deal will expire, I would imagine. If Janssen wants to continue, it will be with Biodexa. After all, this Midatech deal is done like dinner. There will never be a good Bioasis press release again.
I predict that xB3-001 and all the other little xB3s will find their ways into deals in very short order after the buyout is complete. However, will they and the platform first be sold off and will the new, private owners be making those deals?
There is no way to predict that. The xB3s and the platform have been downplayed, shelved, for a long time, ever since Bioasis started talking about "accretive" strategic alliances.
I contend it was a purposeful underselling of xB3 to hide its value and to position lots of other awful things to happen, such as this deal and the possible selloff of those under-promoted xB3 assets that may not figure into the future of Biodexa, at all, other than a wee cashing up.
jd